Aurora Cannabis Inc.

Aurora Cannabis Inc.

Aurora Cannabis Inc. is a world-renowned integrated cannabis company with an industry-leading reputation for continuously elevating and setting the global cannabis industry standard.
Medical Marijuana State Programs
Company Details
Drug Manufacturers - Specialty & Generic
Fiscal year-end
June 30
Vancouver, BC
Number of Patients
67,484 at 9/30/18
Financials (Pro Forma 6/30)
Cash on hand
Fixed investment
Shareholders’ equity
$4.40 billion
Revenues – last quarter
Adj. gross margin
Capital Structure
Capital structure
Last financing
Last Equity Fin $345mm Convertible Notes at US$7.23
Basic shares
Diluted shares

Aurora Cannabis Inc. News

19 Apr

The cannabis industry is poised for its biggest 420 yet

The “Black Friday” for Cannabis is expected to be bigger than ever this year.

19 Apr

Aurora Cannabis: A Wise Decision

In the cannabis space, something investors and companies alike need to keep a watchful eye on are mergers and acquisitions. Especially as large players arise from the dirt, they will be sure to buy into...

18 Apr

Aurora Cannabis launches search for Canada's Top Budmaster ™

EDMONTON , April 18, 2019 /CNW/ - Calling all Canadian budtenders! Aurora Cannabis is kicking off the search for Canada's Top Budmaster ™ through a national competition that will recognize cannabis...

18 Apr

Hempco: Aurora To The Rescue

[ Please note that all currency references are in Canadian dollar except if indicated otherwise .] Hempco Food and Fiber Inc ( HMPPF ) ( Toronto Venture Exchange symbol HEMP; Food Processing; Shares...

18 Apr

Marijuana Stock Aurora Cannabis Just Got Another Vote of Confidence

Aurora Cannabis stock edged up following a bullish note from Cowen & Co. that applauded management’s competitive positioning of the company.

18 Apr

How Aurora Cannabis (ACB) Stock Gets to $11

While not bullish on Aurora Cannabis (ACB) long term, the stock could still reach $11 in the short term.  The cannabis sector has several catalysts to push stocks higher before the oncoming flood of supply...

18 Apr

Why The Hemp Business Of Aurora Cannabis May Be Better Than Expected

source: seeking alpha For some time I haven't thought too much of the impact of hemp sales on the performance of Aurora Cannabis ( ACB ) in the short term, primarily because it appears the global market...

18 Apr

Aurora Cannabis Provides Update On German Cannabis Production Tender

Public Appeal Process Completed Facility Construction to Begin in May 2019 TSX | NYSE: ACB EDMONTON , April 18, 2019 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB)...

17 Apr

Aurora Cannabis Inc. (ACB) Gains As Market Dips: What You Should Know

Aurora Cannabis Inc. (ACB) closed at $8.96 in the latest trading session, marking a +0.9% move from the prior day.

17 Apr

Asia Commercial Bank -- Moody's announces completion of a periodic review of ratings of Asia Commercial Ban

Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Asia Commercial Bank and other ratings that are associated with the same analytical unit. The review was conducted...

Load more

About Aurora Cannabis Inc.

Aurora is one of the world’s largest and fastest growing cannabis companies. Following the acquisition of MedReleaf, the company has more than 1,500 employees, 11 facilities, and a funded annual production capacity of more than 500,000 kilograms per year. The Company is vertically integrated and horizontally diversified across every key segment of the cannabis value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis, and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company’s purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. Aurora’s growing constellation of subsidiaries and strategic partnerships provide differentiation in terms of geographic reach, production, technology, product offering, and execution.

With a growing number of countries adopting medical cannabis legislation, the Company has embarked on an aggressive international expansion strategy that currently sees Aurora with operations and/or sales in 22 countries across five continents.

"Through our wholly owned subsidiaries, strategic investments, and global partnerships, Aurora provides a wide range of premium quality cannabis and hemp products and services, develops innovative technologies, promotes cannabis consumer health and wellness, and delivers an exceptional customer experience across all its brands.

Aurora’s operations span multiple continents and focuses on both the medical and recreational cannabis production and sales, patient education and clinic counselling services, home hydroponic cultivation, extraction technologies and delivery systems, and hemp-based food health products.

We operate around the globe pursuing new and emerging cannabis markets where possible through our owned network of import, export and wholesale distributors, and our e-commerce and mobile applications."

Corporate Governance

Aurora Cannabis Inc.’s ISS Governance QualityScore as of January 28, 2019 is 10. The pillar scores are Audit: 2; Board: 10; Shareholder Rights: 9; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Features Aurora Cannabis Inc.

Canadian Operations

  • Multiple state-of-the-art facilities in operation or under construction in four provinces
  • Recent acquisitions of CanniMed and MedReleaf leave the company with nine facilities in Canada
  • Ownership of CanvasRx, the largest operator of cannabis clinics in Canada with 35 clinics open
  • Strong product portfolio with Aurora, CanniMed, and MedReleaf brands and wellness brands including San Rafael ’71, Woodstock, and AltaVie
  • Same-day delivery in Alberta and innovative mobile ordering app
  • Supply agreements with 12 provinces and territories
  • Agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart to distribute and sell medical cannabis
  • 40 clinical studies completed or ongoing
  • Large investment portfolio including TGOD, Radient Technologies, Hempco, Alcanna (formerly Liquor Stores N.A.), and more

Global Operations

  • Active in five continents and 22 countries
  • 22.9% ownership of Australia’s Cann Group (ASX: CAN)
  • 51% ownership of Aurora Nordic in Denmark
  • Ownership of German distribution company Pedanios
  • Wholly owned subsidiary ICC Labs gives the company a platform in Latin America
  • Acquired European hemp company Agropro and sister company Borela
  •  Supply agreements in Italy, South Africa, Luxembourg, and Mexico
  • Import permit from the Polish Ministry of Health
  • Approved for the first cannabis cultivation facility in Malta
  • Structured investment in spin-off Australis Capital, which positions the company to benefit from eventual U.S. legalization


Terry Booth
Founder, CEO
Mr. Stephen Dobler
Founder, Pres & Director
Glen Ibbott
Chief Financial Officer

Participation in events


Edmonton Alberta, Canada
31 Mar 2019
Medicine Hat Alberta, Canada
12 Feb 2019
$ 9.00
Share volume:
2.523 M
Total value:
19.436 M
Market cap:
9.118 B

Hours (MST)

6:00 - 18:00

Closed now

6:00 - 18:00
6:00 - 18:00
6:00 - 18:00
6:00 - 18:00